Softway Medical
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Softway Medical - overview
Established
1979
Location
-, -, France
Primary Industry
Healthcare IT
About
Based in France, Softway Medical specializes in developing innovative healthcare technology solutions, including software and systems integration that enhance operational workflows in medical environments. Softway Medical provides comprehensive software solutions for the healthcare sector. Founded in 1979, the company has maintained a focus on improving healthcare processes through technology. The company is headquartered in France.
In October 2025, Bain Capital acquired Softway Medical from Five Arrows and Naxicap Partners. Groupe Softway Medical delivers tailored software development, systems integration, and data hosting solutions specifically designed for the healthcare industry. Their offerings aim to streamline workflows for healthcare professionals and improve patient care through advancements in artificial intelligence, serving hospitals, medical imaging facilities, and biological laboratories across France and Europe. The company's commitment to data security and ethical practices supports healthcare providers in navigating modern technological challenges effectively.
Their revenue model is primarily based on subscription services and long-term agreements with healthcare clients, ensuring continued access to vital healthcare solutions and support. Looking ahead, Softway Medical plans to launch new products designed to enhance their existing healthcare solutions, with specific release dates yet to be announced. The firm is also targeting expansion into new geographical markets across Europe, aiming to broaden its client base by 2025. The recent acquisition by Five Arrows Principal Investments will support these initiatives, enabling the company to invest in technology and marketing strategies to foster growth and enhance service delivery.
Current Investors
Five Arrows, Bain Capital, Naxicap Partners
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Analytics & Performance Software, Application Integration Software, Medical Software
Website
www.groupesoftwaymedical.com
Verticals
Cloud Computing, HealthTech
Total Amount Raised
Subscriber access only
Softway Medical - financials
| Fiscal Year Ended | Dec 31, 2005 | Dec 31, 2006 | Dec 31, 2007 | Dec 31, 2008 | Dec 31, 2009 | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 139,123,533 | - | 22,503,645 | - | - | - | - | - | - | - | - | 9,946,951 | 11,473,084 | 13,961,821 | 18,209,729 | 14,836,792 | 26,649,884 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | 15.3% | 21.7% | 30.4% | (18.5%) | 79.6% | - | - | - |
| EBITDA (USD) | 14,688,398 | - | 1,347,598 | - | - | - | - | - | - | - | - | 176,197 | 279,577 | 904,166 | 755,107 | (263,638) | 1,066,646 | - | - | - |
| Operating Income (USD) | 4,057,591 | - | 1,316,638 | - | - | - | - | - | - | - | - | 75,872 | 85,643 | (135,935) | 434,809 | (632,985) | 229,282 | - | - | - |
| Operating Margin | 2.9% | - | 5.9% | - | - | - | - | - | - | - | - | 0.8% | 0.7% | (1.0%) | 2.4% | (4.3%) | 0.9% | - | - | - |
| % EBITDA Margin | 10.6% | - | 6.0% | - | - | - | - | - | - | - | - | 1.8% | 2.4% | 6.5% | 4.1% | (1.8%) | 4.0% | - | - | - |
| NET Income (USD) | (3,233,356) | - | 721,526 | - | - | - | - | - | - | - | - | 561,877 | 134,543 | 788,707 | 1,081,468 | 262,806 | 320,508 | - | - | - |
| % Net Margin | (2.3%) | - | 3.2% | - | - | - | - | - | - | - | - | 5.6% | 1.2% | 5.6% | 5.9% | 1.8% | 1.2% | - | - | - |
Softway Medical - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | Softway Medical | - | ||||||||
| Secondary Buyout | Completed | Softway Medical | - | ||||||||
| Buyout | Completed | Softway Medical | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.